Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.320 Biomarker group CTD_human Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia. 7214106 1980
Entrez Id: 1356
Gene Symbol: CP
CP
0.010 GeneticVariation group BEFREE We identified a mutation in the ceruloplasmin (Cp) gene in a Japanese family with aceruloplasminemia, some of whose members showed extrapyramidal disorders, cerebellar ataxia, and diabetes mellitus. 7539672 1995
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.310 Biomarker group CTD_human D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. 11198054 2000
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.310 Biomarker group CTD_human Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy. 12211096 2002
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.310 GeneticVariation group BEFREE Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study. 11927839 2002
Entrez Id: 107987479
Gene Symbol: LOC107987479
LOC107987479
0.010 GeneticVariation group BEFREE Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study. 11927839 2002
Entrez Id: 2643
Gene Symbol: GCH1
GCH1
0.010 Biomarker group BEFREE Dopa-responsive dystonia (DRD) is an extrapyramidal disorder caused by deficit of 5,6,7,8-tetrahydrobiopterin (BH4), cofactor for tyrosine hydroxylase (TH). 12101048 2002
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.310 Biomarker group CTD_human Delirium resolving upon switching from risperidone to quetiapine: implication of CYP2D6 genotype. 16000684 2005
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.310 GeneticVariation group BEFREE Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients. 16867246 2006
Entrez Id: 1861
Gene Symbol: TOR1A
TOR1A
0.010 GeneticVariation group BEFREE It was concluded that symptomatic DYT1 mutation carriers do not suffer the distinctive cognitive decline that is seen in other primary degenerative extrapyramidal disorders. 17013905 2006
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.010 Biomarker group BEFREE Our study suggests that AKT1 is a susceptibility gene for schizophrenia in the Chinese population and that the AKT1 gene may play no major role in the therapeutic response to antipsychotics or in chlorpromazine-induced extrapyramidal syndrome. 17915974 2007
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.310 Biomarker group CTD_human Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms. 18480698 2008
Entrez Id: 3356
Gene Symbol: HTR2A
HTR2A
0.300 Biomarker group CTD_human Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms. 18480698 2008
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.010 GeneticVariation group BEFREE For the chlorpromazine-induced extrapyramidal syndrome, the 230-bp allele and the 234-bp allele acted in opposite directions, that is, patients with the 230-bp allele of the (GT)n polymorphism exhibited a lower degree of induced extrapyramidal syndrome. 18408624 2008
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.310 Biomarker group CTD_human A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. 19506579 2009
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.310 Biomarker group CTD_human Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms. 19225277 2009
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
0.300 Biomarker group CTD_human A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. 19506579 2009
Entrez Id: 80704
Gene Symbol: SLC19A3
SLC19A3
0.300 Biomarker group CTD_human Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. 19387023 2009
Entrez Id: 5997
Gene Symbol: RGS2
RGS2
0.010 GeneticVariation group BEFREE Lack of association between antipsychotic-induced Parkinsonism or its subsymptoms and rs4606 SNP of RGS2 gene in African-Caribbeans and the possible role of the medication: the Curacao extrapyramidal syndromes study X. 19156702 2009
Entrez Id: 3358
Gene Symbol: HTR2C
HTR2C
0.010 GeneticVariation group BEFREE The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX. 18562401 2009
Entrez Id: 8622
Gene Symbol: PDE8B
PDE8B
0.300 Biomarker group CTD_human Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene. 20085714 2010
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.010 GeneticVariation group BEFREE The ABCB1 3435 T allele and the ABCB1 2667 T-3435 T haplotype carriers were more frequent among subjects without extrapyramidal syndromes. 20563569 2010
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.010 Biomarker group BEFREE To fully evaluate SLC6A3 as a therapeutic antipshycotic target we investigated association of the gene with responses to chlorpromazine and clozapine and with chlorpromazine-induced extrapyramidal syndrome (EPS) in the Chinese schizophrenia population. 20580759 2010
Entrez Id: 151056
Gene Symbol: PLB1
PLB1
0.010 GeneticVariation group BEFREE Mutations in pantothenate kinase 2 (PANK2) and phospholipase A2 (PLA2G6) cause recessive, childhood-onset extrapyramidal disorders termed pantothenate kinase-associated neurodegeneration (PKAN) and infantile neuroaxonal dystrophy (INAD), respectively. 21496576 2011
Entrez Id: 80025
Gene Symbol: PANK2
PANK2
0.010 GeneticVariation group BEFREE Mutations in pantothenate kinase 2 (PANK2) and phospholipase A2 (PLA2G6) cause recessive, childhood-onset extrapyramidal disorders termed pantothenate kinase-associated neurodegeneration (PKAN) and infantile neuroaxonal dystrophy (INAD), respectively. 21496576 2011